AAPL336.13-0.87 (-0.26%) ▼|ABBV263.96-0.06 (-0.02%) ▼|ABT102.61+0.38 (+0.37%) ▲|ACN181.29-9.00 (-4.73%) ▼|ADBE248.92-3.75 (-1.48%) ▼|AMAT444.57+27.17 (+6.51%) ▲|AMD559.82+14.73 (+2.70%) ▲|AMGN385.65+5.87 (+1.55%) ▲|AMT173.98-1.60 (-0.91%) ▼|AMZN253.71+2.52 (+1.00%) ▲|AVGO357.61+10.31 (+2.97%) ▲|AXP311.56+0.39 (+0.13%) ▲|BA198.20+1.20 (+0.61%) ▲|BAC57.73-0.45 (-0.77%) ▼|BKNG167.90-2.62 (-1.54%) ▼|BLK1,069.78+15.82 (+1.50%) ▲|BMY63.06+0.22 (+0.35%) ▲|BNY153.79+0.77 (+0.50%) ▲|BRK-B509.77+0.57 (+0.11%) ▲|C131.77-0.93 (-0.70%) ▼|CAT808.99+10.42 (+1.30%) ▲|CL87.47-0.26 (-0.30%) ▼|CMCSA22.74-0.17 (-0.74%) ▼|COF202.43+0.39 (+0.19%) ▲|COP131.83-1.36 (-1.02%) ▼|COST895.31+1.38 (+0.15%) ▲|CRM237.92-4.93 (-2.03%) ▼|CSCO109.51-0.73 (-0.66%) ▼|CVS88.84-1.43 (-1.58%) ▼|CVX209.51-2.06 (-0.97%) ▼|DE683.99-1.64 (-0.24%) ▼|DHR211.81-0.69 (-0.32%) ▼|DIS102.67-2.68 (-2.54%) ▼|DUK117.53-1.01 (-0.85%) ▼|EMR149.92+2.52 (+1.71%) ▲|FDX303.65-2.23 (-0.73%) ▼|GD353.05-2.90 (-0.81%) ▼|GE314.27+0.80 (+0.26%) ▲|GEV940.33+15.40 (+1.67%) ▲|GILD150.11-0.78 (-0.52%) ▼|GM82.20-4.42 (-5.10%) ▼|GOOG344.41+0.73 (+0.21%) ▲|GOOGL349.54+2.21 (+0.64%) ▲|GS942.00-9.47 (-1.00%) ▼|HD299.98-2.53 (-0.84%) ▼|HON206.46-0.03 (-0.01%) ▼|IBM229.55-8.20 (-3.45%) ▼|INTC108.60-0.20 (-0.18%) ▼|INTU303.19-9.94 (-3.17%) ▼|ISRG393.33+9.79 (+2.55%) ▲|JNJ269.99-0.23 (-0.09%) ▼|JPM349.67+0.36 (+0.10%) ▲|KO88.25+0.19 (+0.22%) ▲|LIN460.40+1.92 (+0.42%) ▲|LLY1,152.93+0.49 (+0.04%) ▲|LMT533.38-4.71 (-0.88%) ▼|LOW192.49-1.70 (-0.88%) ▼|LRCX288.11+18.80 (+6.98%) ▲|MA565.24-0.49 (-0.09%) ▼|MCD248.24-0.24 (-0.10%) ▼|MDLZ60.85-1.19 (-1.92%) ▼|MDT92.13-0.64 (-0.69%) ▼|META665.75-16.56 (-2.43%) ▼|MMM165.89+1.18 (+0.72%) ▲|MO69.52-0.18 (-0.26%) ▼|MRK146.87-0.28 (-0.19%) ▼|MS202.58-0.94 (-0.46%) ▼|MSFT493.78-3.97 (-0.80%) ▼|MU1,015.80+38.30 (+3.92%) ▲|NEE80.47-0.81 (-1.00%) ▼|NFLX71.79-3.52 (-4.67%) ▼|NKE35.51-0.85 (-2.34%) ▼|NOW135.47-3.00 (-2.17%) ▼|NVDA222.27+2.93 (+1.34%) ▲|ORCL147.61-2.98 (-1.98%) ▼|PEP129.75-3.91 (-2.93%) ▼|PFE27.66+0.02 (+0.07%) ▲|PG146.39-1.16 (-0.79%) ▼|PLTR177.64+1.40 (+0.79%) ▲|PM188.62-1.86 (-0.98%) ▼|QCOM177.72-10.99 (-5.82%) ▼|RTX194.00+0.46 (+0.24%) ▲|SBUX95.83-0.84 (-0.87%) ▼|SCHW105.25+0.62 (+0.59%) ▲|SO85.52-1.24 (-1.43%) ▼|SPG205.32+0.85 (+0.42%) ▲|T25.40+0.01 (+0.04%) ▲|TMO651.45-6.87 (-1.04%) ▼|TMUS168.18+1.73 (+1.04%) ▲|TSLA364.27-1.93 (-0.53%) ▼|TXN266.64+8.50 (+3.29%) ▲|UBER70.50-0.37 (-0.52%) ▼|UNH376.90+1.69 (+0.45%) ▲|UNP279.37-3.11 (-1.10%) ▼|UPS99.06-1.11 (-1.11%) ▼|USB60.06-0.19 (-0.32%) ▼|V368.29-1.64 (-0.44%) ▼|VZ48.09-0.24 (-0.50%) ▼|WFC86.12-0.77 (-0.89%) ▼|WMT106.73-0.06 (-0.06%) ▼|XOM163.54+0.27 (+0.17%) ▲|AAPL336.13-0.87 (-0.26%) ▼|ABBV263.96-0.06 (-0.02%) ▼|ABT102.61+0.38 (+0.37%) ▲|ACN181.29-9.00 (-4.73%) ▼|ADBE248.92-3.75 (-1.48%) ▼|AMAT444.57+27.17 (+6.51%) ▲|AMD559.82+14.73 (+2.70%) ▲|AMGN385.65+5.87 (+1.55%) ▲|AMT173.98-1.60 (-0.91%) ▼|AMZN253.71+2.52 (+1.00%) ▲|AVGO357.61+10.31 (+2.97%) ▲|AXP311.56+0.39 (+0.13%) ▲|BA198.20+1.20 (+0.61%) ▲|BAC57.73-0.45 (-0.77%) ▼|BKNG167.90-2.62 (-1.54%) ▼|BLK1,069.78+15.82 (+1.50%) ▲|BMY63.06+0.22 (+0.35%) ▲|BNY153.79+0.77 (+0.50%) ▲|BRK-B509.77+0.57 (+0.11%) ▲|C131.77-0.93 (-0.70%) ▼|CAT808.99+10.42 (+1.30%) ▲|CL87.47-0.26 (-0.30%) ▼|CMCSA22.74-0.17 (-0.74%) ▼|COF202.43+0.39 (+0.19%) ▲|COP131.83-1.36 (-1.02%) ▼|COST895.31+1.38 (+0.15%) ▲|CRM237.92-4.93 (-2.03%) ▼|CSCO109.51-0.73 (-0.66%) ▼|CVS88.84-1.43 (-1.58%) ▼|CVX209.51-2.06 (-0.97%) ▼|DE683.99-1.64 (-0.24%) ▼|DHR211.81-0.69 (-0.32%) ▼|DIS102.67-2.68 (-2.54%) ▼|DUK117.53-1.01 (-0.85%) ▼|EMR149.92+2.52 (+1.71%) ▲|FDX303.65-2.23 (-0.73%) ▼|GD353.05-2.90 (-0.81%) ▼|GE314.27+0.80 (+0.26%) ▲|GEV940.33+15.40 (+1.67%) ▲|GILD150.11-0.78 (-0.52%) ▼|GM82.20-4.42 (-5.10%) ▼|GOOG344.41+0.73 (+0.21%) ▲|GOOGL349.54+2.21 (+0.64%) ▲|GS942.00-9.47 (-1.00%) ▼|HD299.98-2.53 (-0.84%) ▼|HON206.46-0.03 (-0.01%) ▼|IBM229.55-8.20 (-3.45%) ▼|INTC108.60-0.20 (-0.18%) ▼|INTU303.19-9.94 (-3.17%) ▼|ISRG393.33+9.79 (+2.55%) ▲|JNJ269.99-0.23 (-0.09%) ▼|JPM349.67+0.36 (+0.10%) ▲|KO88.25+0.19 (+0.22%) ▲|LIN460.40+1.92 (+0.42%) ▲|LLY1,152.93+0.49 (+0.04%) ▲|LMT533.38-4.71 (-0.88%) ▼|LOW192.49-1.70 (-0.88%) ▼|LRCX288.11+18.80 (+6.98%) ▲|MA565.24-0.49 (-0.09%) ▼|MCD248.24-0.24 (-0.10%) ▼|MDLZ60.85-1.19 (-1.92%) ▼|MDT92.13-0.64 (-0.69%) ▼|META665.75-16.56 (-2.43%) ▼|MMM165.89+1.18 (+0.72%) ▲|MO69.52-0.18 (-0.26%) ▼|MRK146.87-0.28 (-0.19%) ▼|MS202.58-0.94 (-0.46%) ▼|MSFT493.78-3.97 (-0.80%) ▼|MU1,015.80+38.30 (+3.92%) ▲|NEE80.47-0.81 (-1.00%) ▼|NFLX71.79-3.52 (-4.67%) ▼|NKE35.51-0.85 (-2.34%) ▼|NOW135.47-3.00 (-2.17%) ▼|NVDA222.27+2.93 (+1.34%) ▲|ORCL147.61-2.98 (-1.98%) ▼|PEP129.75-3.91 (-2.93%) ▼|PFE27.66+0.02 (+0.07%) ▲|PG146.39-1.16 (-0.79%) ▼|PLTR177.64+1.40 (+0.79%) ▲|PM188.62-1.86 (-0.98%) ▼|QCOM177.72-10.99 (-5.82%) ▼|RTX194.00+0.46 (+0.24%) ▲|SBUX95.83-0.84 (-0.87%) ▼|SCHW105.25+0.62 (+0.59%) ▲|SO85.52-1.24 (-1.43%) ▼|SPG205.32+0.85 (+0.42%) ▲|T25.40+0.01 (+0.04%) ▲|TMO651.45-6.87 (-1.04%) ▼|TMUS168.18+1.73 (+1.04%) ▲|TSLA364.27-1.93 (-0.53%) ▼|TXN266.64+8.50 (+3.29%) ▲|UBER70.50-0.37 (-0.52%) ▼|UNH376.90+1.69 (+0.45%) ▲|UNP279.37-3.11 (-1.10%) ▼|UPS99.06-1.11 (-1.11%) ▼|USB60.06-0.19 (-0.32%) ▼|V368.29-1.64 (-0.44%) ▼|VZ48.09-0.24 (-0.50%) ▼|WFC86.12-0.77 (-0.89%) ▼|WMT106.73-0.06 (-0.06%) ▼|XOM163.54+0.27 (+0.17%) ▲|
20.1 C
New York
Saturday, September 19, 2026

Tag: investor

newssourceFORcompanyinformationcontent1releasesmarket

Roivant and Priovant to Host Investor Video Conference at 1:00 PM ET on Tuesday, June 17 on Brepocitinib and the Unmet Medical Need in...

BASEL, Switzerland and LONDON and NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) and Priovant Therapeutics today announced that they will host a live investor video conference at 1:00 PM ET on Tuesday, June 17 on brepocitinib, the unmet medical need for patients with dermatomyositis (DM) and the potential role brepocitinib could play in improving the lives of patients with DM.

Lyell Immunopharma Strengthens Clinical and Commercial Capabilities with Key Board and Executive Appointments

SOUTH SAN FRANCISCO, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, today announced the appointment of Mark J. Bachleda, PharmD, MBA as an independent member of the Board of Directors, David Shook, MD as Chief Medical Officer, and Mark Meltz, JD as General Counsel and Corporate Secretary. These appointments, along with the appointment earlier in the year of Jarrad Aguirre, MD, MBA as Senior Vice President, Medical Affairs, further strengthen the Company’s clinical and commercial capabilities.

Long Ridge Energy LLC Announces Timing of First Quarter 2025 Earnings Conference Call

PDF Version

DeFi Development Corp. to Host X Spaces Event: “Solana Lending 101: The Future of Onchain Lending ft. Kamino”

BOCA RATON, FL, June 09, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) today announced that it will host a live X Spaces conversation on Thursday, June 12, 2025, at 1:30 p.m. Eastern Time, titled “Solana Lending 101: The Future of Onchain Lending ft. Kamino.”

ADAR1 Issues Statement on Keros Therapeutics’ Troubling 2025 Director Election Results and Insufficient Capital Return Proposal

Significant Withhold Votes from Directors Mary Ann Gray and Alpna Seth Underscores Need for Change and a More Disciplined Capital Allocation Strategy AUSTIN, Texas, June...

SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About...

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from allegations that Semler Scientific may have issued materially misleading business information to the investing public.

Novaturas Group Reports Audited Results for 2024

The tour operator Novaturas Group reported audited revenues of EUR 201 million for 2024, having served 239 thsnd. travelers across the Baltic States. Compared to 2023, this represents a 3.6% decline in revenue and an 8% decrease in traveler numbers (down from 259 thsnd. in 2023). Despite a profitable final quarter, the company ended the year with a net loss.

Meriaura Group Plc: The merger of Meriaura Group Plc and Summa Defence Oy has been completed, sale of Meriaura Group Oy shares, directed acquisition...

Meriaura Group Plc
Company announcement                 9 June 2025 at 8.00 p.m. (CEST)                
        
THE MERGER OF MERIAURA GROUP PLC AND SUMMA DEFENCE OY HAS BEEN COMPLETED, SALE OF MERIAURA GROUP OY SHARES, DIRECTED ACQUISITION AND CANCELLATION OF OWN SHARES, CHANGE OF COMPANY NAME AND CEO

Not for release, publication or distribution, directly or indirectly, in or into the United States, Canada, New Zealand, Australia, Japan, Hong Kong, Singapore or South Africa or any other jurisdiction where such distribution or publication would be unlawful.

Disrupting the Stock Contract Trading Industry, Leading a New Era of Global Investment – Stockrich Launches AI Quantitative System

New York, NY, June 09, 2025 (GLOBE NEWSWIRE) -- Against the backdrop of rapid advancements in global financial technology, compliance intelligent financial platform Stockrich is reshaping the logic of stock contract trading through unprecedented technological innovation. With its self-developed AI quantitative system, high-frequency algorithm trading engine, and risk hedging architecture, Stockrich is ushering global investors into a new trading era characterized by "efficiency, transparency, and predictability."

VINFAST REPORTS UNAUDITED FIRST QUARTER 2025 FINANCIAL RESULTS

SINGAPORE, June 9, 2025 /PRNewswire/ -- VinFast Auto Ltd. ("VinFast" or the "Company") (Nasdaq: VFS), a pure-play electric vehicle ("EV") manufacturer with the mission...

Valley National Bancorp to Announce Second Quarter 2025 Earnings

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Valley National Bancorp (NASDAQ:VLY), the holding company for Valley National Bank, announced that it will release its second quarter 2025 earnings before the market opens on Thursday, July 24, 2025.

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IOVA

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) between May 9, 2024 and May 8, 2025, both dates inclusive (the “Class Period”), of the important July 14, 2025 lead plaintiff deadline.

Sharps Technology CEO, Robert Hayes, to Present at the Virtual Investor Summit on June 10, 2025

Presentation to be webcast live at 10:00 AM ET 
Presentation to be webcast live at 10:00 AM ET

Formation Bio Announces First Class of Entrepreneurs in Residence to Drive Pipeline Growth and Strategic Partnerships

NEW YORK, June 9, 2025 /PRNewswire/ -- Formation Bio, an AI-driven pharmaceutical company focused on accelerating drug development, today announced the appointment of its first...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsInvestor

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers